| Literature DB >> 26849846 |
Akshaya Bansal1,2, Haichun Liu1, Muthu Kumara Gnanasammandhan Jayakumar1, Stefan Andersson-Engels3, Yong Zhang1,2.
Abstract
Optogenetics is an emerging powerful tool to investigate workings of the nervous system. However, the use of low tissue penetrating visible light limits its therapeutic potential. Employing deep penetrating near-infrared (NIR) light for optogenetics would be beneficial but it cannot be used directly. This issue can be tackled with upconversion nanoparticles (UCNs) acting as nanotransducers emitting at shorter wavelengths extending to the UV range upon NIR light excitation. Although attractive, implementation of such NIR-optogenetics is hindered by the low UCN emission intensity that necessitates high NIR excitation intensities, resulting in overheating issues. A novel quasi-continuous wave (quasi-CW) excitation approach is developed that significantly enhances multiphoton emissions from UCNs, and for the first time NIR light-triggered optogenetic manipulations are implemented in vitro and in C. elegans. The approach developed here enables the activation of channelrhodopsin-2 with a significantly lower excitation power and UCN concentration along with negligible phototoxicity as seen with CW excitation, paving the way for therapeutic optogenetics.Entities:
Keywords: nanoparticles; near-infrared; optogenetics; quasi-CW; upconversion
Mesh:
Substances:
Year: 2016 PMID: 26849846 DOI: 10.1002/smll.201503792
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281